tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Amplia Therapeutics Announces Cessation of Securities

Story Highlights
Amplia Therapeutics Announces Cessation of Securities

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Amplia Therapeutics ( (AU:ATX) ) has issued an update.

Amplia Therapeutics Limited has announced the cessation of 1,000,000 securities due to the expiry of options without exercise or conversion, effective September 2, 2025. This announcement may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and future growth potential.

The most recent analyst rating on (AU:ATX) stock is a Buy with a A$0.42 price target. To see the full list of analyst forecasts on Amplia Therapeutics stock, see the AU:ATX Stock Forecast page.

More about Amplia Therapeutics

Amplia Therapeutics Limited operates in the biotechnology industry, focusing on the development of innovative therapies for the treatment of cancer and fibrotic diseases.

Average Trading Volume: 7,259,213

Technical Sentiment Signal: Buy

Current Market Cap: A$82.69M

For detailed information about ATX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1